Pfizer and BioNTech recently reported top-line results from a trial of its combination vaccine that was meant to protect against the flu and COVID-19. The partners' combination shot failed to achieve ...

NEW YORK & MAINZ, GERMANY--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, ...

The pharmaceutical company filed its application with the FDA on May 7, and the FDA is expected to finish its approval process by Labor Day weekend.

Let’s dive into details regarding each of the evaluated factors, but first, for quick context: With $143 Bil in market ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to ...

Moderna is taking Pfizer and Germany's BioNTech to court, claiming the rival drugmakers copied its technology in developing their COVID-19 vaccine. In documents filed in U.S. District Court in ...

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...

Just like how the Avengers have repeatedly kept the world safe from Ultron, people need to protect themselves by updating their COVID-19 vaccination with the latest booster. That’s the message Pfizer ...

Health officials say it’s time for most Americans to get another booster dose—this time, with a new Omicron-specific shot made by either Pfizer-BioNTech (for people 12 and older) or Moderna (for ...

The children's parents discussed their decision with ABC News. Three American siblings have received their first dose of the Pfizer-BioNTech COVID-19 vaccine as part of global clinical trials for ...

The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...

Moderna accused Pfizer and BioNTech of copying its "innovative mRNA technology" to develop its popular COVID-19 vaccine. REUTERS/Dado Ruvic/Illustration Moderna is suing Pfizer and its German partner ...